Who Owns HELX?

Franklin Genomic Advancements ETF — Institutional Ownership & 13F Holdings

$33.29

+0.72 (+2.21%)

Market Cap

$16.5M

Shares Outstanding

497,961

Institutional Holders

10

Total Inst. Value

$1.9M

% of Float Held

QoQ Holder Change

Institutional data as of Q1 2025

New Positions

1

Closed Positions

2

Increased

6

Decreased

1

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1Glenview Trust Co$941K32,625
2LPL Financial LLC$482K17,850
3JANE STREET GROUP, LLC$217K8,049
4UBS Group AG$72K2,661
5OSAIC HOLDINGS, INC.$71K2,630
6HALBERT HARGROVE GLOBAL ADVISORS, LLC$69K2,554
7HARBOUR INVESTMENTS, INC.$49K1,823
8CITADEL ADVISORS LLC$1K46,119
9JPMORGAN CHASE & CO$00
10MORGAN STANLEYNew$01

Biggest Buyers & Sellers This Quarter

Top Sellers

FundShares RemovedValue
JANE STREET GROUP, LLC-33K$217K

Related Stocks

Frequently Asked Questions

How many institutional investors hold HELX?

As of Q1 2025, 10 institutional investors report holding HELX (Franklin Genomic Advancements ETF) in their 13F filings.

Which hedge fund owns the most HELX?

The largest institutional holder of HELX is Glenview Trust Co with $941K in shares.

Are institutions buying or selling HELX?

This quarter, 1 institutions opened new positions in HELX and 2 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.